Teflaro is a Intravenous Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Ceftaroline Fosamil.
| Product ID | 0456-0400_0125d943-1b18-45f9-971f-4ee704ec54b7 | 
| NDC | 0456-0400 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Teflaro | 
| Generic Name | Ceftaroline Fosamil | 
| Dosage Form | Powder, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2010-10-29 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA200327 | 
| Labeler Name | Allergan, Inc. | 
| Substance Name | CEFTAROLINE FOSAMIL | 
| Active Ingredient Strength | 400 mg/20mL | 
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2010-10-29 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA200327 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2010-10-29 | 
| Marketing Category | NDA | 
| Application Number | NDA200327 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2010-10-29 | 
| Ingredient | Strength | 
|---|---|
| CEFTAROLINE FOSAMIL | 400 mg/20mL | 
| SPL SET ID: | 3ecde48b-75a2-4beb-9999-369f3f61bb8a | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0456-0400 | Teflaro | ceftaroline fosamil | 
| 0456-0600 | Teflaro | ceftaroline fosamil | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  TEFLARO  85073011  3949340 Live/Registered | ALLERGAN SALES, LLC 2010-06-28 | 
|  TEFLARO  85018295  3935814 Live/Registered | ALLERGAN SALES, LLC 2010-04-20 |